GAGE12C

Q-omics provides the consensus-scored GAGE12C profile across patient tissues and cancer cell-line models. GAGE12C expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SKCM. Additionally, GAGE12C RNA expression shows 54 significant gene co-expression associations, with the highest sampling consensus in SKCM. Together, these results highlight SKCM as cancer lineages where GAGE12C shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes GAGE12C survival associations across molecular data types. GAGE12C RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

GAGE12C data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	SKCM (9)	view →

This table ranks reproducible GAGE12C RNA expression–survival associations across cancer types. High GAGE12C expression shows unfavorable associations in SKCM. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .046). Together, the overview and detailed table identify SKCM as the clearest survival context for GAGE12C RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.333	0.780	.046	9	view →

Pink = unfavorable, green = favorable. all 1 lineages →

GAGE12C-SKCM (OS)

Explore this curve interactively →